Simeon George, Director at HTG Molecular Diagnostics, holds 0.00 shares in HTG Molecular Diagnostics (Ticker: HTGMQ), holds 3.33M shares in Nkarta (Ticker: NKTX), holds 1.05M shares in Crispr Therapeutics AG (Ticker: CRSP). Most recently, Simeon George ― shares of HTG Molecular Diagnostics on ― for an estimated value of ―.
Simeon George latest transaction was an Uninformative Buy of ―.
What was Simeon George's most profitable transaction?
Simeon George’s most profitable transaction was an Informative Buy of PRNB stock on October 22, 2019. The return on the trade was 222.40%.
What is Simeon George's role in HTG Molecular Diagnostics?
Simeon George's role in HTG Molecular Diagnostics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.